Johnson & Johnson (JNJ) stock tumbled Wednesday, though the company issued strong 2026 guidance, as Boston Scientific (BSX) and Medtronic (MDT) continue undercutting its electrophysiology business. Electrophysiology tools study the heart's rhythm. Pulsed field ablation, or PFA, is an electrophysiology tool that uses high-voltage electrical pulses to destroy problematic heart tissue, thus restoring normal rhythm for people with atrial fibrillation.… ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Boston Scientific’s planned $14.5 billion acquisition of Penumbra started off the year with a bang. The two fast-growing, cardiovascular companies complement each other, with Boston Scientific seeing an opportunity to enter new markets, and Penumbra expecting its devices to gain a wider global reach. Boston Scientific CEO Mike Mahoney explained how they reached a de ...

Boston Scientific Corporation (NYSE:BSX) is included in our list of the best stocks to buy right now. Boston Scientific (BSX) Expands Urology Portfolio with Valencia Deal, Analysts Emphasize Organic Growth A dose bottle of the medication is in the medical tech's hand On January 12, 2026, Boston Scientific Corporation (NYSE:BSX) shared an expansion update, announcing a definitive agreement to acquire Valencia Technologies. With this move, the company expands its Urology franchise into implantable tibial ...

NEW YORK and NEW ORLEANS, Jan. 16, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Penumbra, Inc. (NYSE: PEN) to Boston Scientific Corporation (NYSE: BSX). Under the terms of the proposed transaction, shareholders of Penumbra will receive $374.00 in cash or 3.8721 shares of Boston Scientific common stock, subject to proration, for each share of Penumbra that they own. KSF is seekin ...

Boston Scientific Corporation (NYSE:BSX) is one of the best blue-chip stocks to buy for 2026. Boston Scientific Corporation (NYSE:BSX) said on January 12 that it has agreed to acquire Valencia Technologies, maker of the FDA-approved eCoin System for urge urinary incontinence. The coin-sized implant, placed near the ankle, uses tibial nerve stimulation to help control bladder activity and showed a 68% response rate in clinical trials. The acquisition expands Boston Scientific’s urology and pelvic health por ...

A downtrend has been apparent in Boston Scientific (BSX) lately with too much selling pressure. The stock has declined 6.3% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is overso ...

SHANGHAI, CHINA - 2025/11/08: The logo of Boston Scientific with the slogan "Innovate for Life" is shown at the 8th China International Import Expo. (Photo by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesBoston Scientific (BSX) shares have decreased by 8.5% over the past 5 trading days. This recent drop highlights revived worries regarding the initial earnings dilution stemming from its Penumbra acquisition, yet such significant declines often raise a chall ...

格隆汇1月16日｜奥本海默将波士顿科学公司目标股价从125美元下调至100美元。 ...

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!Towards the end of October, I concluded that Boston Scientific ( BSX ) was continuing its M&A playbook, just as organic achievements were impressive. Supported by nearly 20% organic sales growth, ...

Market Overview - Global markets are facing a mix of geopolitical risks, political uncertainty, and structural tailwinds, making stock selection critical for investors in 2026 [2] - U.S., European, and Japanese equities are expected to rise in 2026, but gains will be smaller compared to the previous year, with over half of market participants anticipating a correction [3] - Investor sentiment has been affected by recent "black swan" events, creating a "wall of worry" that markets have historically climbed [4] Methodology for Stock Selection - The list of best stocks was curated from the top 40 hedge fund holdings tracked by Insider Monkey, assessing analyst sentiment and upside potential [7] - The strategy has historically outperformed the market, returning 427.7% since May 2014, significantly beating its benchmark [8] Company Highlights Meta Platforms, Inc. (NASDAQ:META) - Hedge Fund Holders: 273, Upside Potential: 26.30% [10] - Wells Fargo lowered its price target from $802 to $795 but remains optimistic about Q4 earnings and 2026 outlook, projecting EPS of $31-$32 [11] - The company is expected to benefit from the release of the next-generation Llama model and associated AI-driven products [12] - Meta has secured long-term power purchase agreements for electricity from U.S. nuclear plants, reflecting rising demand for AI and data centers [13] - Focuses on social media and immersive technologies through its Family of Apps and Reality Labs segments [14] Boston Scientific Corporation (NYSE:BSX) - Hedge Fund Holders: 102, Upside Potential: 28.00% [15] - Announced acquisition of Valencia Technologies to expand its Urology franchise into implantable tibial nerve stimulation [16] - The eCoin System addresses a large market of overactive bladder, with only 19% of affected adults receiving treatment [16] - Goldman Sachs lowered its price target from $124 to $112 while maintaining a 'Buy' rating, focusing on organic growth in 2026 [18] MercadoLibre, Inc. (NASDAQ:MELI) - Hedge Fund Holders: 109, Upside Potential: 28.50% [19] - Over 90% of analysts are bullish, with a consensus price target of $2,800 [19] - Cantor Fitzgerald highlighted the potential for revenue growth driven by AI efficiencies, despite the sector trading 20% below medium-term valuations [20] - Wedbush reduced its price target from $2,800 to $2,700 while maintaining an 'Outperform' rating, citing increased spending and competition concerns [21] - Known for its leading e-commerce and fintech ecosystem in Latin America [22] Uber Technologies, Inc. (NYSE:UBER) - Hedge Fund Holders: 143, Upside Potential: 28.70% [23] - Facing a lawsuit that could significantly impact financial exposure and regulatory standing [24] - Management asserts that safety measures are in place, including background checks and partnerships with advocacy groups [25] - Operates a global technology platform connecting consumers with mobility, delivery, and freight services [26] Snowflake Inc. (NYSE:SNOW) - Hedge Fund Holders: 102, Upside Potential: 29.40% [27] - Announced acquisition of Observe to enhance its AI Data Cloud capabilities [28] - The platform aims to address the $51.7 billion IT operations management market, focusing on efficient anomaly detection [29] - Analyst sentiment is mixed, with Barclays downgrading the stock while Goldman Sachs initiated coverage with a 'Buy' rating [30] - Focuses on cloud-native data warehousing and enabling secure, scalable AI and analytics [31]